Stockreport

Nuvectis Pharma GAAP EPS of -$0.24 beats by $0.01 [Seeking Alpha]

Nuvectis Pharma, Inc.  (NVCT) 
PDF Cash, cash equivalents, and short-term investments were $17.2 million as of September 30, 2024, compared to $19.1 million as of December 31, 2023. More on Nuvectis Ph [Read more]